Pravastatin Potassium is an HMG-CoA reductase inhibitor, a class of statin medications widely used to manage cholesterol levels and reduce the risk of cardiovascular events such as heart attack and stroke.… Read more
Pravastatin Potassium is an HMG-CoA reductase inhibitor, a class of statin medications widely used to manage cholesterol levels and reduce the risk of cardiovascular events such as heart attack and stroke. By effectively inhibiting hepatic cholesterol biosynthesis, this active pharmaceutical ingredient plays a critical role in treating hyperlipidemia and promoting cardiovascular health. This category provides essential reference standards for analytical testing and quality control of this medication. Laboratories rely on these high-quality compounds, including pharmacopeial and non-pharmacopeial impurities, to support rigorous impurity profiling and method validation throughout the drug development lifecycle. Furthermore, stable isotope labelled compounds are available to ensure accuracy in complex quantitative bioanalytical methods and pharmacokinetic studies. These critical resources are fundamental for ensuring the stability, safety, and regulatory compliance of pharmaceutical products containing this therapeutic agent.